New drug targets brain inflammation to slow Alzheimer's
NCT ID NCT05318976
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tested an experimental drug called XPro1595 in 208 people with early Alzheimer's disease who also had signs of brain inflammation. The goal was to see if the drug could improve memory, thinking, and daily function compared to a placebo over 24 weeks. Researchers also checked for safety and changes in brain health markers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
INmune Bio Investigational Site
Darlinghurst, New South Wales, 2010, Australia
-
INmune Bio Investigational Site
Macquarie Park, New South Wales, 2113, Australia
-
INmune Bio Investigational Site
Adelaide, South Australia, 5011, Australia
-
INmune Bio Investigational Site
Box Hill, Victoria, 3128, Australia
-
INmune Bio Investigational Site
Carlton, Victoria, 3053, Australia
-
INmune Bio Investigational Site
Ivanhoe, Victoria, 3079, Australia
-
INmune Bio Investigational Site
Parkville, Victoria, 3050, Australia
-
INmune Bio Investigational Site
Nedlands, Western Australia, 6009, Australia
-
INmune Bio Investigational Site
Kelowna, V1Y 1Z9, Canada
-
INmune Bio Investigational Site
Ottawa, K1Z 1G3, Canada
-
INmune Bio Investigational Site
Sherbrooke, J1L 0H8, Canada
-
INmune Bio Investigational Site
Toronto, M3B 2S7, Canada
-
INmune Bio Investigational Site
Toronto, M4G 3E8, Canada
-
INmune Bio Investigational Site
West Vancouver, V7T 1C5, Canada
-
INmune Bio Investigational Site
Brno, 60200, Czechia
-
INmune Bio Investigational Site
Pilsen, 30100, Czechia
-
INmune Bio Investigational Site
Prague, 10000, Czechia
-
INmune Bio Investigational Site
Prague, 16000, Czechia
-
INmune Bio Investigational Site
Rychnov nad Kněžnou, 51601, Czechia
-
INmune Bio Investigational Site
Bron, 69500, France
-
INmune Bio Investigational Site
Nantes, 44800, France
-
INmune Bio Investigational Site
Toulouse, 31059, France
-
INmune Bio Investigational Site
Berlin, 10629, Germany
-
INmune Bio Investigational Site
Chemnitz, 09111, Germany
-
INmune Bio Investigational Site
Bialystok, 15-756, Poland
-
INmune Bio Investigational Site
Bydgoszcz, 85-133, Poland
-
INmune Bio Investigational Site
Wroclaw, 53-659, Poland
-
INmune Bio Investigational Site
Barcelona, 08028, Spain
-
INmune Bio Investigational Site
Barcelona, 08222, Spain
-
INmune Bio Investigational Site
Córdoba, 14004, Spain
-
INmune Bio Investigational Site
Madrid, 28006, Spain
-
INmune Bio Investigational Site
Seville, 41009, Spain
-
INmune Bio Investigational Site
Valencia, 46017, Spain
-
INmune Bio Investigational Site
Valencia, 46026, Spain
-
INmune Bio Investigational Site
Birmingham, B16 8LT, United Kingdom
-
INmune Bio Investigational Site
Bristol, BS32 4SY, United Kingdom
-
INmune Bio Investigational Site
Guildford, GU2 7YD, United Kingdom
-
INmune Bio Investigational Site
London, W1G 9JF, United Kingdom
-
INmune Bio Investigational Site
Motherwell, ML1 4UF, United Kingdom
-
INmune Bio Investigational Site
Plymouth, PL7 8BT, United Kingdom
-
INmune Bio Investigational Site
Winchester, S021 1HU, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Could your brain help unlock Alzheimer's secrets?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can lifestyle choices after a stroke extend life and prevent a second one?